Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health IncfiledCriticalAmersham Health Inc
Publication of MY132225ApublicationCriticalpatent/MY132225A/en
A CONTRAST AGENT FOR ULTRASONOGRAPHY COMPRISING AN O/W TYPE EMULSION USEFUL FOR CONTRASTING LEFT VENTRICLE AND/OR MYOCARDIAL PERFUSION OF AN MAMMAL AT A SMALL DOSE, WHEREIN SAID EMULSION COMPRISES A DISPERSION PHASE COMRISING A WATER-IMMISCIBLE LIQUID HAVING A BOILING POINT OF FROM 5 °C TO 60°C AND A CONTINUOUS PHASE COMPRISING AN AQUEOUS MEDIUM, AND SAID EMULSION IS SUBJECTED TO AN ULTRASONIC TREATMENT.
MYPI96005891995-03-131996-02-15Contrast agent for ultrasonography
MY132225A
(en)
Use of [[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)- -phenyl]hydrazono]-propanedinitrile for treatment and prophylaxis of myocardium ischemia, method of myocardium ischemia treatment